Shanchol (oral cholera vaccine) / Sanofi 
Welcome,         Profile    Billing    Logout  

3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Shanchol (oral cholera vaccine) / Sanofi
Hillchol, NCT05507229: A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of ® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of ®(BBV131).

Active, not recruiting
3
1800
RoW
Hillchol vaccine, Shanchol Vaccine
Bharat Biotech International Limited
Cholera
07/22
10/22
NCT04760236: Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™

Completed
3
2530
RoW
Oral Cholera Vaccine Simplified (OCV-S), Shanchol™
International Vaccine Institute, EuBiologics Co.,Ltd
Cholera
12/22
03/23
Hillchol131, NCT05732766: To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)

Recruiting
3
1800
RoW
Hillchol vaccine
Bharat Biotech International Limited
Cholera
03/23
08/23

Download Options